These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Starvation- and antibiotics-induced formation of persister cells in Pseudomonas aeruginosa. Mlynarcik P; Kolar M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):58-67. PubMed ID: 27886280 [TBL] [Abstract][Full Text] [Related]
6. Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes. Knudsen GM; Ng Y; Gram L Appl Environ Microbiol; 2013 Dec; 79(23):7390-7. PubMed ID: 24056460 [TBL] [Abstract][Full Text] [Related]
8. Persister eradication: lessons from the world of natural products. Keren I; Mulcahy LR; Lewis K Methods Enzymol; 2012; 517():387-406. PubMed ID: 23084949 [TBL] [Abstract][Full Text] [Related]
9. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929 [TBL] [Abstract][Full Text] [Related]
10. Human Granulocyte Macrophage Colony-Stimulating Factor Enhances Antibiotic Susceptibility of Pseudomonas aeruginosa Persister Cells. Choudhary GS; Yao X; Wang J; Peng B; Bader RA; Ren D Sci Rep; 2015 Nov; 5():17315. PubMed ID: 26616387 [TBL] [Abstract][Full Text] [Related]
11. Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters. Rudenko N; Golovchenko M; Kybicova K; Vancova M Parasit Vectors; 2019 May; 12(1):237. PubMed ID: 31097026 [TBL] [Abstract][Full Text] [Related]
12. Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa. Liebens V; Defraine V; Knapen W; Swings T; Beullens S; Corbau R; Marchand A; Chaltin P; Fauvart M; Michiels J Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630188 [TBL] [Abstract][Full Text] [Related]
13. Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics. Defraine V; Fauvart M; Michiels J Drug Resist Updat; 2018 May; 38():12-26. PubMed ID: 29857815 [TBL] [Abstract][Full Text] [Related]
14. Lethal Effect of Photodynamic Treatment on Persister Bacteria. Oppezzo OJ; Forte Giacobone AF Photochem Photobiol; 2018 Jan; 94(1):186-189. PubMed ID: 28881420 [TBL] [Abstract][Full Text] [Related]
15. Survival of Pseudomonas aeruginosa exposed to sunlight resembles the phenom of persistence. Forte Giacobone AF; Oppezzo OJ J Photochem Photobiol B; 2015 Jan; 142():232-6. PubMed ID: 25553385 [TBL] [Abstract][Full Text] [Related]
16. Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells. Lechner S; Patra P; Klumpp S; Bertram R J Mol Microbiol Biotechnol; 2012; 22(6):381-91. PubMed ID: 23363876 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa fosfomycin resistance mechanisms affect non-inherited fluoroquinolone tolerance. De Groote VN; Fauvart M; Kint CI; Verstraeten N; Jans A; Cornelis P; Michiels J J Med Microbiol; 2011 Mar; 60(Pt 3):329-336. PubMed ID: 21212150 [TBL] [Abstract][Full Text] [Related]
18. Persister cells: molecular mechanisms related to antibiotic tolerance. Lewis K Handb Exp Pharmacol; 2012; (211):121-33. PubMed ID: 23090599 [TBL] [Abstract][Full Text] [Related]
19. Controlling Pseudomonas aeruginosa persister cells by weak electrochemical currents and synergistic effects with tobramycin. Niepa TH; Gilbert JL; Ren D Biomaterials; 2012 Oct; 33(30):7356-65. PubMed ID: 22840233 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. Möker N; Dean CR; Tao J J Bacteriol; 2010 Apr; 192(7):1946-55. PubMed ID: 20097861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]